Todd Anderson

Professor of Medicine

Cardiac Sciences

Vice Dean

Cumming School of Medicine

Medical Degree

University of Calgary, 1985

Contact information


Office: 403.220.2587

Research and teaching

Research areas

  • Atherosclerosis
  • Endothelial dysfunction


Dr. Todd Anderson is a Professor of Cardiac Sciences at the University of Calgary. He is the former Head of the Department of Cardiac Sciences, and former Director of the Libin Cardiovascular Institute of Alberta. He assumed a new role as the Vice Dean in the Cumming School of Medicine in September 2019.
Dr. Anderson was awarded his medical degree from the University of Calgary in 1985 and then undertook residency training in Internal Medicine, Cardiology and Interventional Cardiology in Calgary. He pursued further research training in coronary physiology at the Brigham and Women’s Hospital at Harvard Medical School and then returned to Calgary. He has been on staff since 1995.
His current research interests include the treatment of dyslipidemia and generation of lipid guidelines, the evaluation of appropriateness in clinical care delivery and the assessment of vascular function in health and disease particularly in women with microvascular angina.


1. Anderson, TJ, Gregoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J JR. Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, NG DS, Pearson GJ, Yates GM, Stone JA, Ur E. Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel, Can J Cardio 2014 April 30(4):377-80. PubMed ID 24589194

2. Fitchett DH, Mancini GB, Gregoire J, Anderson T, McPherson R. Stratification and selection for statin therapy: Going beyond Framingham. Can J of Cardiol 2014 Jun; 30 (6):667-70. PubMed ID: 24882539

3. Anderson, TJ New hope for lipid-lowering beyond statins: Effect of IMROVE-IT on understanding of atherosclerosis prevention. Can J of Cardiol 2015 May;31(5):585-PubMed ID: 25936485

4. Anderson, TJ. Chest pain after percutaneous coronary intervention: More than meets the eye. Can J of Cardiol. 2015 Aug; 31(8):960-2 doi: 10.1016/j.cjca.2015.04.010. Pub Med: 26100215

5. Freiheit, EA, Hogan DB, Patten SB, Wunsch H, Anderson T, Ghali WA, Knudtson M, Maxwell CJ Frailty trajectories after treatment for coronary artery disease in older patients Circ.Cardiovasc Qual Outcomes. 2016 May 9;9(3):230-8 PubMed ID 27166209

6. Rishi Puri, Steven Nissen, Ransi Somaratne, Leslie Cho, John JP Kastelein, Christi Ballantyne, Wolfgang Koenig, Todd J. Anderson, Jinyuan Yang, Helina Kassahun, Scott Wasserman, Robert Scott, Marilyn Borgman, Stephen Nicholls Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global assessment of plaque regression with a PCSK9 antibody as measured by intravascular ultrasound (GLAGOV). Amer Heart Journal June 2016; Vol 176; 83-92 PubMed: 27264224

7. Rabea Asleh, Nina Levy, Gheorge Doros, Tina Costacou, Jennifer Robinson, Shany Blum, Hagit Goldenstein, William Boden, Debra Simmons, Megan Lacy, George Grunberger, Todd Anderson, Andrew Levy. Haptoglobin genotype as a determinant of benefit or harm from Niacin for participants with diabetes J of Amer Coll of Cardiology May 2016;Vol 67, Issue 21 2553-2554. PubMed: 27230052

8. Anderson TJ, Grégoire J, Pearson GJ, Barry AR, Couture P, Dawes M, Francis GA, Genest J Jr, Grover S, Gupta M, Hegele RA, Lau DC, Leiter LA, Lonn E, Mancini GB,McPherson R, Ngui D, Poirier P, Sievenpiper JL, Stone JA, Thanassoulis G, Ward R. 2016 Canadian Cardiovascular Society Guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 2016 Nov;32(11):1263-128 PMID:27712954

9. Anderson TJ Bringing structure to the art of lipid-lowering therapy J AM Coll Cardiol 2016 Dec 6; 68(22):2422-2424 PMID: 27908346

10. Nicholls SJ, Puri R, Anderson T, Ballantyne CM, Cho L, Kastelein JJ, Koenig W, Somaratne R, Kassahun H, Yang J, Wasserman SM, Scott R, Ungi I, Podolec J, Ophuis AO, Cornel JH, Borgman M, Brennan DM, Nissen. SE Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial JAMA. 2016 Dec 13; 316(22):2373-2384 PMID: 27846344